BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatmentWorld Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
2
Nouhoum Bouare, Dolores Vaira, Andre Gothot, Jean Delwaide, Sebastien Bontems, Laurence Seidel, Paul Gerard, Christiane Gerard. Prevalence of HIV and HCV infections in two populations of Malian women and serological assays performancesWorld Journal of Hepatology 2012; 4(12): 365-373 doi: 10.4254/wjh.v4.i12.365
3
Ikram Sghaier, Leila Mouelhi, Noor A. Rabia, Ezzedine Ghazoueni, Wassim Y. Almawi, Besma Yacoubi Loueslati. IL-10 and IL-28B gene variants as predictors of sustained response to peginterferon and ribavirin therapy in chronic HCV infectionCytokine 2017; : 154008 doi: 10.1016/j.cyto.2017.03.007
4
Lorena Puchades Renau, Marina Berenguer. Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapiesHemodialysis International 2018; 22: S8 doi: 10.1111/hdi.12647
5
Daniel P Webster, Paul Klenerman, Jane Collier, Katie JM Jeffery. Development of novel treatments for hepatitis CThe Lancet Infectious Diseases 2009; 9(2): 108 doi: 10.1016/S1473-3099(09)70020-9
6
Ester Aparicio, Mariona Parera, Sandra Franco, Nuria Pérez-Alvarez, Cristina Tural, Bonaventura Clotet, Miguel Angel Martínez, Esper Georges Kallas. IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-α and Ribavirin Therapy Treatment Failure in HCV/HIV-1 Coinfected PatientsPLoS ONE 2010; 5(10): e13771 doi: 10.1371/journal.pone.0013771
7
H. LaRue, L. Rigali, J.-M. Balada-Llasat, P. Pancholi. Performance of the Abbott RealTime and Roche Cobas TaqMan Hepatitis C Virus (HCV) Assays for Quantification of HCV GenotypesJournal of Clinical Microbiology 2012; 50(5): 1769 doi: 10.1128/JCM.06723-11
8
Mariana N. Batista, Bruno M. Carneiro, Ana Cláudia S. Braga, Paula Rahal. Caffeine inhibits hepatitis C virus replication in vitroArchives of Virology 2015; 160(2): 399 doi: 10.1007/s00705-014-2302-1
9
Satoshi Yoshimi, Hidenori Ochi, Eisuke Murakami, Takuro Uchida, Hiromi Kan, Sakura Akamatsu, C. Nelson Hayes, Hiromi Abe, Daiki Miki, Nobuhiko Hiraga, Michio Imamura, Hiroshi Aikata, Kazuaki Chayama, Ranjit Ray. Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader AssayPLOS ONE 2015; 10(6): e0130022 doi: 10.1371/journal.pone.0130022
10
E. CHOLONGITAS, G. V. PAPATHEODORIDIS. Review article: novel therapeutic options for chronic hepatitis CAlimentary Pharmacology & Therapeutics 2008; 27(10): 866 doi: 10.1111/j.1365-2036.2008.03644.x
11
Yugo Miyagi, Hideyuki Nomura, Nobuyuki Yamashita, Hironori Tanimoto, Tsunefumi Shibuya, Kiyoaki Ito, Naohiko Masaki, Masashi Mizokami. Estimation of two real-time RT-PCR assays for quantitation of hepatitis C virus RNA during PEG-IFN plus ribavirin therapy by HCV genotypes and IL28B genotypeJournal of Infection and Chemotherapy 2013; 19(1): 63 doi: 10.1007/s10156-012-0452-1
12
Claire Gondeau, Lydiane Pichard-Garcia, Patrick Maurel. Cellular models for the screening and development of anti-hepatitis C virus agentsPharmacology & Therapeutics 2009; 124(1): 1 doi: 10.1016/j.pharmthera.2009.05.010
13
Infectious Causes of Cancer2018; : 106 doi: 10.1002/9780470753651.ch7
14
Reem Beleid, Donna Douglas, Norman Kneteman, Kamaljit Kaur. Helical Peptides Derived from Lactoferrin Bind Hepatitis C Virus Envelope Protein E2Chemical Biology & Drug Design 2008; 72(5): 436 doi: 10.1111/j.1747-0285.2008.00715.x
15
Katja Seme, Maja Vrhovac, Tina Močilnik, Mojca Matičič, Gorazd Lešničar, Zvonko Baklan, Jelka Meglič Volkar, Mojca Rajter, Srečko Štepec, Maja Lunar, Mario Poljak. Hepatitis C virus genotypes in 1,504 patients in Slovenia, 1993-2007Journal of Medical Virology 2009; 81(4): 634 doi: 10.1002/jmv.21427
16
Takahiro Azakami, C. Nelson Hayes, Hitomi Sezaki, Mariko Kobayashi, Norio Akuta, Fumitaka Suzuki, Hiromitsu Kumada, Hiromi Abe, Daiki Miki, Masataka Tsuge, Michio Imamura, Yoshiiku Kawakami, Shoichi Takahashi, Hidenori Ochi, Yusuke Nakamura, Naoyuki Kamatani, Kazuaki Chayama. Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapyJournal of Medical Virology 2011; 83(6): 1048 doi: 10.1002/jmv.22069
17
Virus de l’hépatite C : étude des génotypes au Congo (Brazzaville)Journal Africain d'Hépato-Gastroentérologie 2014; 8(1): 16 doi: 10.1007/s12157-014-0506-3
18
KASL clinical practice guidelines: Management of Hepatitis CClinical and Molecular Hepatology 2014; 20(2): 89 doi: 10.3350/cmh.2014.20.2.89
19
A.C.G. Jardim, Z. Igloi, J.F. Shimizu, V.A.F.F.M. Santos, L.G. Felippe, B.F. Mazzeu, Y. Amako, M. Furlan, M. Harris, P. Rahal. Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitroAntiviral Research 2015; 115: 39 doi: 10.1016/j.antiviral.2014.12.018
20
R. Navinés, P. Castellví, J. Moreno-España, D. Gimenez, M. Udina, S. Cañizares, C. Diez-Quevedo, M. Valdés, R. Solà, R. Martín-Santos. Depressive and anxiety disorders in chronic hepatitis C patients: Reliability and validity of the Patient Health QuestionnaireJournal of Affective Disorders 2012; 138(3): 343 doi: 10.1016/j.jad.2012.01.018
21
I. M. V. G. de Carvalho-Mello, J. E. M. Filho, M. S. Gomes-Gouvea, F. de Mello Malta, A. T. L. de Queiroz, J. R. R. Pinho, F. J. Carrilho. Molecular evidence of horizontal transmission of hepatitis C virus within couplesJournal of General Virology 2010; 91(3): 691 doi: 10.1099/vir.0.015594-0
22
Daisuke Sasaki, Kazuyuki Sugahara, Naoko Inokuchi, Katunori Yanagihara, Hiroo Hasegawa, Sayaka Mori, Yasuaki Yamada, Shimeru Kamihira. Screening for genetic heterogeneity in the interferon sensitivity determining region of the hepatitis C virus genome by polymerase chain reaction with melting curve analysisClinical Chemistry and Laboratory Medicine 2008; 46(7) doi: 10.1515/CCLM.2008.186
23
Kareena L Schnabl, Matt Sibbald, Wayne L Gold, Pak Cheung Chan, Khosrow Adeli. A Patient with a Leg Rash, Pedal Edema, Renal Failure, and ThrombocytopeniaClinical Chemistry 2009; 55(7): 1419 doi: 10.1373/clinchem.2008.116541
24
Laura J. Lester, Suneal K. Agarwal. Sexually Transmitted Infections and Sexually Transmitted Diseases2011; : 553 doi: 10.1007/978-3-642-14663-3_42
25
Adriana Sánchez-García, Clara Patricia Ríos-Ibarra, Ana Rosa Rincón-Sánchez, Rocío Ortiz-López, Aurora Garza-Juárez, Jesús Morlett-Chávez, Herminia Martínez-Rodríguez, Ana María Rivas-Estilla. Use of proteomic analysis tools to identify HCV-proteins down-regulated by acetylsalicylic acidAnnals of Hepatology 2013; 12(5): 725 doi: 10.1016/S1665-2681(19)31313-4
26
R. Pelazas González, E. González Reimers, R. Alemán Valls, E. García-Valdecasas, M.J. de La Vega Prieto, M.A. Gómez Rodríguez, J. López Prieto, F. Santolaria fernández. Osteopatía en el paciente afecto de infección por virus CRevista Española de Enfermedades Metabólicas Óseas 2009; 18(1): 15 doi: 10.1016/S1132-8460(09)70766-4
27
Matthew M. Riggs, Timothy T. Bergsma, James A. Rogers, Marc R. Gastonguay, G. Mani Subramanian, Cecil Chen, Matt Devalaraja, Alfred E. Corey, Haiying Sun, Jing Yu, Daniel S. Stein. Population Pharmacokinetics and Exposure-Response of Albinterferon Alfa-2bThe Journal of Clinical Pharmacology 2012; 52(4): 475 doi: 10.1177/0091270011399576
28
Alessandra Della Rossa, Antonia Tavoni, Stefano Bombardieri. Rheumatology2011; : 1609 doi: 10.1016/B978-0-323-06551-1.00160-3
29
Cuong Minh Duong, Dariusz Piotr Olszyna, Mary-Louise McLaws. Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: a cross-sectional studyBMC Public Health 2015; 15(1) doi: 10.1186/s12889-015-1532-9
30
Ikram Sghaier, Leila Mouelhi, Ezzedine Gazouani, Virginie Morel, Yacoubi Loueslati Besma, Etienne Brochot. Roles of ITPA and IL28B genotypes in chronic Hepatitis C patients treated with peginterferon plus ribavirin in Tunisian populationJournal of Clinical Virology 2015; 69: 184 doi: 10.1016/j.jcv.2015.06.102
31
Lydiane Pichard-Garcia, Philippe Briolotti, Dominique Larrey, Antonio Sa-Cunha, Bertrand Suc, Sylvain Laporte, Patrick Maurel. HepatocytesMethods in Molecular Biology 2010; 640: 447 doi: 10.1007/978-1-60761-688-7_24
32
Sylvie Lagaye, Hong Shen, Bertrand Saunier, Michelina Nascimbeni, Jesintha Gaston, Pierre Bourdoncle, Laurent Hannoun, Pierre-Philippe Massault, Anaïs Vallet-Pichard, Vincent Mallet, Stanislas Pol. Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: A relevantex vivomodel of liver infectionHepatology 2012; 56(3): 861 doi: 10.1002/hep.25738
33
Kazuya Kamada, Ikuo Shoji, Lin Deng, Chie Aoki, Suratno Lulut Ratnoglik, Takaji Wakita, Hak Hotta. Generation of a recombinant reporter hepatitis C virus useful for the analyses of virus entry, intra-cellular replication and virion productionMicrobes and Infection 2012; 14(1): 69 doi: 10.1016/j.micinf.2011.08.009
34
Romil Saxena. Essentials of Anatomic Pathology2011; : 1771 doi: 10.1007/978-1-4419-6043-6_44
35
Kazuaki Chayama, C. Nelson Hayes, Hiromi Abe, Daiki Miki, Hidenori Ochi, Yoshiyasu Karino, Joji Toyota, Yusuke Nakamura, Naoyuki Kamatani, Hitomi Sezaki, Mariko Kobayashi, Norio Akuta, Fumitaka Suzuki, Hiromitsu Kumada. IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis CThe Journal of Infectious Diseases 2011; 204(1): 84 doi: 10.1093/infdis/jir210
36
Stephane Pecou, Nathalie Moinard, Marie Walschaerts, Christophe Pasquier, Myriam Daudin, Louis Bujan. Ribavirin and pegylated interferon treatment for hepatitis C was associated not only with semen alterations but also with sperm deoxyribonucleic acid fragmentation in humansFertility and Sterility 2009; 91(3): 933.e17 doi: 10.1016/j.fertnstert.2008.07.1755
37
Shaihana Abdulrahman Almatrrouk, Anthony W Oliver, Lynne Hampson, Ian N Hampson. Targeting gap junction intercellular communication as a potential therapy for HCV-related carcinogenesisFuture Virology 2014; 9(7): 679 doi: 10.2217/fvl.14.50
38
Khayriyyah Mohd Hanafiah, Mary Garcia, David Anderson. Point-of-care testing and the control of infectious diseasesBiomarkers in Medicine 2013; 7(3): 333 doi: 10.2217/bmm.13.57
39
Cintia Costi, Cláudia Maria Dornelles da Silva, Nicole Nascimento Da Fré, Tarciana Grandi, Fernanda Irma Hamester, Arnaldo Zaha, Christian Niel, Maria Lucia Rosa Rossetti. Colorimetric microwell plate reverse-hybridization assay for detection and genotyping of hepatitis C virusJournal of Virological Methods 2009; 162(1-2): 75 doi: 10.1016/j.jviromet.2009.07.017
40
María Sara Sixtos-Alonso, Fausto Sánchez-Muñoz, Juan Francisco Sánchez-Ávila, Rosalba Avalos Martínez, Aaron Domínguez López, Florencia Vargas Vorácková, Misael Uribe. IFN-stimulated Gene Expression Is a Useful Potential Molecular Marker of Response to Antiviral Treatment with Peg-IFNα 2b and Ribavirin in Patients with Hepatitis C Virus Genotype 1Archives of Medical Research 2011; 42(1): 28 doi: 10.1016/j.arcmed.2011.01.001
41
E. Aparicio, S. Franco, M. Parera, C. Andres, C. Tural, B. Clotet, M. A. Martinez. Complexity and Catalytic Efficiency of Hepatitis C Virus (HCV) NS3 and NS4A Protease Quasispecies Influence Responsiveness to Treatment with Pegylated Interferon plus Ribavirin in HCV/HIV-Coinfected PatientsJournal of Virology 2011; 85(12): 5961 doi: 10.1128/JVI.00308-11
42
Francesco Giuseppe Foschi, Anna Chiara Dall’Aglio, Arianna Lanzi, Giorgio Marano, Sara Savini, Pietro Andreone, Mauro Bernardi, Giuseppe Francesco Stefanini. Cryoglobulinemia in elderly patients with HCV-related chronic hepatitisWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2010; 1(2): 72-74 doi: 10.4292/wjgpt.v1.i2.72
43
Ma. Sara Sixtos-Alonso, Rosalba Avalos-Martinez, Ricardo Sandoval-Salas, Margarita Dehesa-Violante, Ignacio García-Juarez, Alejandro Chávez-Ayala, Aarón Domínguez-López, Florencia Vargas-Vorácková, Liz Toapanta-Yanchapaxi, Luis Manuel Amezcua-Guerra, Misael Uribe, Juan Francisco Sánchez-Ávila. A Genetic Variant in the Interleukin 28B Gene As a Major Predictor for Sustained Virologic Response in Chronic Hepatitis C Virus InfectionArchives of Medical Research 2015; 46(6): 448 doi: 10.1016/j.arcmed.2015.07.001
44
Na Zhao, Jinxia Liu, Dianxing Sun. Detection of HCV genotypes 1b and 2a by a reverse transcription loop-mediated isothermal amplification assayJournal of Medical Virology 2017; 89(6): 1048 doi: 10.1002/jmv.24747
45
Saneyuki Ujino, Saori Yamaguchi, Kunitada Shimotohno, Hiroshi Takaku. Combination Therapy for Hepatitis C Virus with Heat-Shock Protein 90 Inhibitor 17-AAG and Proteasome Inhibitor MG132Antiviral Chemistry and Chemotherapy 2010; 20(4): 161 doi: 10.3851/IMP1479
46
Peyman Eini, Mojgan Mamani, Fatemeh Keshavarz, Abbas Moradi. Assessment of the Response to Treatment in Patients with the Hepatitis C Virus Infection: A Quantitative Study by Focusing on Virologic and Biochemical ResponsesAvicenna Journal of Clinical Microbiology and Infection 2016; 3(4) doi: 10.17795/ajcmi-41142
47
Antonio Craxì, Giacomo Laffi, Anna Linda Zignego. Hepatitis C virus (HCV) infection: A systemic diseaseMolecular Aspects of Medicine 2008; 29(1-2): 85 doi: 10.1016/j.mam.2007.09.017
48
G. J. Ebrahim. The Five Hepatitis VirusesJournal of Tropical Pediatrics 2011; 57(6): 401 doi: 10.1093/tropej/fmr099
49
Ana CG Jardim, Cíntia Bittar, Renata PA Matos, Lílian HT Yamasaki, Rafael A Silva, João RR Pinho, Roberta M Fachini, Claudia MA Carareto, Isabel MVG de Carvalho-Mello, Paula Rahal. Analysis of HCV quasispecies dynamic under selective pressure of combined therapyBMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-61
50
Mariam Tajir, Mustapha Elmachad, Nawal Kabbaj, Fatima Zahra Laarabi, Amina Barkat, Naima Amrani, Abdelaziz Sefiani. Frequency of IL28B rs12979860 Single-Nucleotide Polymorphism Alleles in Newborn Infants and in Patients with Chronic Hepatitis C in MoroccoGenetic Testing and Molecular Biomarkers 2012; 16(8): 981 doi: 10.1089/gtmb.2011.0353
51
Pieter Leyssen, Erik De Clercq, Johan Neyts. Molecular strategies to inhibit the replication of RNA virusesAntiviral Research 2008; 78(1): 9 doi: 10.1016/j.antiviral.2008.01.004
52
E. Ozbek, T. Ozekinci, S. Mese, S. Atmaca. Hepatitis C Virus Genotypes are Changing in the Southeast of TurkeyBiotechnology & Biotechnological Equipment 2009; 23(4): 1521 doi: 10.2478/V10133-009-0021-7
53
Jieting Huang, Ru Xu, Min Wang, Qiao Liao, Ke Huang, Zhengang Shan, Qingzhu You, Chengyao Li, Xia Rong, Yongshui Fu. Association of HLA‐DQB1*03:01 and DRB1*11:01 with spontaneous clearance of hepatitis C virus in Chinese Li ethnicity, an ethnic group genetically distinct from Chinese Han ethnicity and infected with unique HCV subtype Journal of Medical Virology 2019; 91(10): 1830 doi: 10.1002/jmv.25531
54
Zeynep Altın, Gülden Diniz, Ayfer Çolak, Betül Koyuncu, Serhat Özer, Fatih Aslan, Belkıs Ünsal. Influence of pegylated interferon and ribavirin on insulin resistance and metabolic factors in chronic hepatitis CTurkish Journal of Biochemistry 2019; 44(2): 170 doi: 10.1515/tjb-2018-0163
55
Regina Maria Santos de Amorim, Alexandre Coelho, Elisabeth Lampe, Tainá Raiol, Regina Maria Bringel Martins. Genetic diversity of hepatitis C virus quasispecies in chronic renal failure patients in Midwest BrazilArchives of Virology 2014; 159(8): 1917 doi: 10.1007/s00705-014-1994-6
56
KASL clinical practice guidelines: management of hepatitis CClinical and Molecular Hepatology 2016; 22(1): 76 doi: 10.3350/cmh.2016.22.1.76
57
R. Liu, M. Tewari, R. Kong, R. Zhang, P. Ingravallo, R. Ralston. A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entryAntiviral Research 2010; 86(2): 172 doi: 10.1016/j.antiviral.2010.02.316
58
Robert A. Fridell, Dike Qiu, Chunfu Wang, Lourdes Valera, Min Gao. Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System Antimicrobial Agents and Chemotherapy 2010; 54(9): 3641 doi: 10.1128/AAC.00556-10
59
H. Ochi, C. N. Hayes, H. Abe, Y. Hayashida, T. Uchiyama, N. Kamatani, Y. Nakamura, K. Chayama. Toward the Establishment of a Prediction System for the Personalized Treatment of Chronic Hepatitis CJournal of Infectious Diseases 2012; 205(2): 204 doi: 10.1093/infdis/jir726
60
Tarciana Grandi, Cláudia Maria Dornelles da Silva, Karine Medeiros Amaral, Paulo Dornelles Picon, Cintia Costi, Nicole Nascimento da Fré, Marilu Fiegenbaum, Christian Niel, Maria Lucia Rosa Rossetti. Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B geneMemórias do Instituto Oswaldo Cruz 2013; 108(1): 48 doi: 10.1590/S0074-02762013000100008
61
E. J. Lim, J. Torresi. Viruses and Human CancerRecent Results in Cancer Research 2014; 193: 113 doi: 10.1007/978-3-642-38965-8_7
62
Hidenori Ochi, Daiki Miki, C. Nelson Hayes, Hiromi Abe, Yasufumi Hayashida, Michiaki Kubo, Kazuaki Chayama. IFNL4/IL-28B haplotype structure and its impact on susceptibility to hepatitis C virus and treatment response in the Japanese population Journal of General Virology 2014; 95(6): 1297 doi: 10.1099/vir.0.060103-0
63
Maria Alice Sant'Anna Zarife, Eliana Almeida Gomes Reis, Theomira Mauadie Azevedo Carmo, Gisele Barreto Lopes, Emilia Carolina Malafaia Brandão, Helder Reis Silva, Nelma Santana, Olindo Assis Martins-Filho, Mitermayer Galvão Reis. Increased frequency of CD56BrightNK-cells, CD3−CD16+CD56−NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25HighT-cells control potentially viremia in blood donors with HCVJournal of Medical Virology 2009; 81(1): 49 doi: 10.1002/jmv.21340
64
Nurdan Tözün, Özdal Ersoy, Fatih Eren, Veysel Tahan. Detection of Bacteria, Viruses, Parasites and FungiNATO Science for Peace and Security Series A: Chemistry and Biology 2010; : 239 doi: 10.1007/978-90-481-8544-3_10
65
Camila Malta Romano, Isabel M. V. Guedes de Carvalho-Mello, Leda F. Jamal, Fernando Lucas de Melo, Atila Iamarino, Marco Motoki, João Renato Rebello Pinho, Edward C. Holmes, Paolo Marinho de Andrade Zanotto, Bradley S. Schneider. Social Networks Shape the Transmission Dynamics of Hepatitis C VirusPLoS ONE 2010; 5(6): e11170 doi: 10.1371/journal.pone.0011170
66
Mette Brandt Eriksen, Louise Bruun Jørgensen, Henrik Krarup, Alex Lund Laursen, Peer Brehm Christensen, Axel Møller, Poul Schlichting, Carla Kuiken, Jens Bukh, Nina Weis. Molecular and epidemiological profiles of hepatitis C virus genotype 4 in DenmarkJournal of Medical Virology 2010; 82(11): 1869 doi: 10.1002/jmv.21896
67
Prodromos Hytiroglou. Practical Hepatic Pathology: A Diagnostic Approach2011; : 225 doi: 10.1016/B978-0-443-06803-4.00018-6
68
Sajid Mansoor, Aneela Javed, Amjad Ali, Atika Mansoor. Heterogeneous genomic locations within NS3, NS4A and NS4B identified for genotyping and subtyping of Hepatitis C virus: A simple genome analysis approachInfection, Genetics and Evolution 2016; 44: 61 doi: 10.1016/j.meegid.2016.06.031
69
Jakovljevic B. Mihajlo, Miјailovic D. Zeljko, Popovska Jovicic D. Biljana, Canovic S. Predrag, Gajovic M. Olgica, Jovanovic R. Mirjana, Petrovic S. Dejan, Milovanovic Z. Olivera, Djordjevic D. Natasa. Assessment of Viral Genotype Impact to the Cost-Effectiveness and Overall Costs of Care for Peg-Interferon-2α + Ribavirine Treated Chronic Hepatitis C PatientsHepatitis Monthly 2013; 13(6) doi: 10.5812/hepatmon.6750
70
Asghar Ashrafi Hafez, Rasoul Baharlou, Seyed Dawood Mousavi Nasab, Abbas Ahmadi Vasmehjani, Mohammad Shayestehpour, Negar Joharinia, Nayeb Ali Ahmadi. Molecular Epidemiology of Different Hepatitis C Genotypes in Serum and Peripheral Blood Mononuclear Cells in Jahrom City of IranHepatitis Monthly 2014; 14(4) doi: 10.5812/hepatmon.16391
71
C. Nelson Hayes, Kazuaki Chayama. Interferon stimulated genes and innate immune activation following infection with hepatitis B and C virusesJournal of Medical Virology 2017; 89(3): 388 doi: 10.1002/jmv.24659
72
Mahmoud Mohamed Bahgat, Ahmed Atef Ibrahim, Dina Nadeem Abd-Elshafy, Ahmed Atef Mesalam, Hossam Eid Gewaid, Amany Abd-Elghany Ismaeil, Ahmed Mohamed El-Waseef, Amany Sayed Maghraby, Ahmed Barakat Barakat, Mohamed Abd-Elhafez El-Far, Hossam El-Din Ahmed Ghanem, Amro Mahmoud Mohamed, Mohamed Ahmed Ali. Characterization of NS3 protease from an Egyptian HCV genotype 4a isolateArchives of Virology 2009; 154(10): 1649 doi: 10.1007/s00705-009-0500-z
73
Phillip A Furman, Angela M Lam, Eisuke Murakami. Nucleoside analog inhibitors of hepatitis C viral replication: recent advances, challenges and trendsFuture Medicinal Chemistry 2009; 1(8): 1429 doi: 10.4155/fmc.09.88